RN

Rodger Novak

Venture Partner at SR One Capital Management

Switzerland

Overview

Work Experience

  • Chair of the Board of Directors

    2023 - Current

  • Chair of the Board of Directors

    2022

  • Chair of the Board of Directors

    2020

  • Venture Partner

    2020

  • Board Member

    2014

  • President & Chair Board of Directors

    2017 - 2023

  • Chief Executive Officer

    2013 - 2017

  • VP Head TSU Infectious Diseases Global R&D

    2012 - 2013

  • Founder and Chief Operating Officer

    2006 - 2012

  • Deputy Head Antibiotic Research Institute

    2003 - 2005

    Position accountable for the management of entire organization in preparation for spin-off from Sandoz/Novartis to foundation of Nabriva.

  • University Professor

    2000 - 2003

Relevant Websites